Curosurf - 10122-510-03 - (poractant alfa)

Alphabetical Index


Drug Information of Curosurf

Product NDC: 10122-510
Proprietary Name: Curosurf
Non Proprietary Name: poractant alfa
Active Ingredient(s): 80    mg/mL & nbsp;   poractant alfa
Administration Route(s): ENDOTRACHEAL
Dosage Form(s): SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of Curosurf

Product NDC: 10122-510
Labeler Name: Cornerstone Therapeutics Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020744
Marketing Category: NDA
Start Marketing Date: 19991118

Package Information of Curosurf

Package NDC: 10122-510-03
Package Description: 3 mL in 1 VIAL, GLASS (10122-510-03)

NDC Information of Curosurf

NDC Code 10122-510-03
Proprietary Name Curosurf
Package Description 3 mL in 1 VIAL, GLASS (10122-510-03)
Product NDC 10122-510
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name poractant alfa
Dosage Form Name SUSPENSION
Route Name ENDOTRACHEAL
Start Marketing Date 19991118
Marketing Category Name NDA
Labeler Name Cornerstone Therapeutics Inc.
Substance Name PORACTANT ALFA
Strength Number 80
Strength Unit mg/mL
Pharmaceutical Classes Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA]

Complete Information of Curosurf


General Information